IPO registrations (S-1, F-1) · Registrants
MeiraGTx Holdings plc
- SEC CIK
- 1735438 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2018-05-14, last 2018-06-04; 1 initial registration, 3 amendments
- Outcome
- Final prospectus filed 2018-06-08; declared effective 2018-06-07
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Business address
- 655 THIRD AVENUE, SUITE 1115, New York, NY 10017
- EIN
- 98-1448305
- Ticker
- MGTX (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- MeiraGTx Holdings plc on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2018-06-04)
- Final price
- $15.00 per share, within the range (424B4 filed 2018-06-08, an initial public offering)
- Shares sold
- 5,000,000
- Gross proceeds
- $75,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol MGTX
- Lead underwriters
- Merrill Lynch; Barclays (1,250,000 shares)
- Syndicate
- BofA Securities; Evercore (1,150,000); Chardan (400,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: MeiraGTx Holdings plc EXACT (CIK (EXACT))
- Person page: Arnold J Levine Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 8
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2018-05-14 | S-1 | S-1 (registration) | MeiraGTx Holdings plc | 0001193125-18-162609 ↗ |
| 2018-05-23 | S-1/A | S-1/A (amendment) | MeiraGTx Holdings plc | 0001193125-18-171970 ↗ |
| 2018-05-29 | S-1/A | S-1/A (amendment) | MeiraGTx Holdings plc | 0001193125-18-176071 ↗ |
| 2018-06-04 | S-1/A | S-1/A (amendment) | MeiraGTx Holdings plc | 0001193125-18-182614 ↗ |
| 2018-06-07 | EFFECT | EFFECT (declared effective) | MeiraGTx Holdings plc | 9999999995-18-001444 ↗ |
| 2018-06-08 | 424B4 | 424B4 (final prospectus) | MeiraGTx Holdings plc | 0001193125-18-188208 ↗ |
| 2019-07-16 | EFFECT | EFFECT (declared effective) | MeiraGTx Holdings plc | 9999999995-19-001617 ↗ |
| 2019-07-19 | EFFECT | EFFECT (declared effective) | MeiraGTx Holdings plc | 9999999995-19-001656 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-06-04 | S-1/A | registration statement | $14.00–$16.00 | 5,000,000 | - | Nasdaq MGTX | 5 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2018-06-08 | 424B4 | final prospectus | $15.00 | 5,000,000 | $75,000,000 | Nasdaq MGTX | 5 | primary document; price sentence, shares headline, proceeds table, underwriting table 3, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| EDELMAN JOSEPH | Director; Director,TenPercentOwner; TenPercentOwner | 17 | 2018–2026 | ||
| Forbes Alexandria | Director,Officer | President and CEO; President & CEO; PRESIDENT & CEO | 41 | 2018–2026 | |
| Giroux Richard | Officer | CFO & COO; Chief Operating Officer | 36 | 2018–2026 | |
| Harris Keith R. | Director | 12 | 2018–2026 | ||
| LEVINE ARNOLD J | Director | 5 | 2018–2022 | person page Fuzzy | |
| MARCUS JOEL S | Director | 8 | 2018–2022 | ||
| Mendoza Neil | Director | 9 | 2018–2026 | ||
| Moss Gregory S. | Director | 1 | 2018 | ||
| Naylor Stuart | Director,Officer; Officer | Chief Development Officer; Chief Dev. Officer; CHIEF DEV. OFFICER; CHIEF SCI OFCR, OPHTHALMOLOGY | 35 | 2018–2026 | |
| PERCEPTIVE ADVISORS LLC | Director,TenPercentOwner; TenPercentOwner | 17 | 2018–2026 | ||
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | Director; Director,TenPercentOwner; TenPercentOwner | 14 | 2018–2026 | ||
| SHENK THOMAS E | Director | 12 | 2018–2026 | ||
| Hukkelhoven Ellen | Director | 9 | 2018–2026 | ||
| Breedis Katherine | Officer | Chief Financial Officer | 3 | 2018–2019 | |
| Indyk Martin | Director | 7 | 2019–2024 | ||
| Gottlieb Bruce | Officer | General Counsel | 2 | 2019 | |
| Seligman Nicole | Director | 10 | 2019–2026 | ||
| Wollin Robert J | Officer | General Counsel and Secretary; GENERAL COUNSEL AND SECRETARY | 17 | 2020–2026 | |
| Zeldin Robert K | Officer | Chief Medical Officer; CHIEF MEDICAL OFFICER | 19 | 2020–2026 | |
| Yu Debra | Director | 6 | 2022–2026 | ||
| JOHNSON & JOHNSON | TenPercentOwner | 1 | 2022 | ||
| Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | 3 | 2022–2023 | ||
| Sanofi | TenPercentOwner | 1 | 2024 | ||
| Fleck Penny Renee | Officer | CHIEF DEVELOPMENT OFFICER | 2 | 2026 | |
| SEBULSKY ALAN | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | MeiraGTx Holdings plc | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | Arnold J Levine | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), NY first:
- Acorda Therapeutics, Inc. NY
- BRAINSTORM CELL THERAPEUTICS INC. NY
- ANAVEX LIFE SCIENCES CORP. NY
- CytRx Oncology Corp NY
- Omrix Biopharmaceuticals, Inc. NY
- Protara Therapeutics, Inc. NY
- COGNITION THERAPEUTICS INC NY
- Bavarian Nordic A/S / ADR NY
- Qrons Inc. NY
- Prevail Therapeutics Inc. NY
In other datasets, the same topic (Health) in NY:
- Nonprofit: AABR FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health